Alan L. Jakimo, JD

Alan Jakimo, JD

Senior Public Policy Fellow Regenerative Medicine Foundation

Alan L. Jakimo is a member of the Board of Directors of Regenerative Medicine Foundation, which he joined in 2019. He also serves RMF as a Senior Policy Research Fellow, a position that he also held at Genetics Policy Institute, a predecessor of RMF. Mr. Jakimo began working with GPI in the fields of policy research and patient advocacy in 2007. His involvement in the field of developmental biology began during his tenure as a securities and technology transactions lawyer in the New York office of Brown & Wood LLP, which merged in 2001 with Sidley & Austin LLP (ultimately becoming Sidley Austin LLP). He joined a predecessor of Brown & Wood as an associate in 1980 and, after taking retired partner status from Sidley Austin in 2017, he joined the investment banking group at T.R. Winton & Company, LLC. Mr. Jakimo is an Adjunct Professor of Law at Hofstra University where he teaches courses on health law and how the law influences the discovery-to-development-to-commercialization pathway followed by regulated medical products and therapies. He also serves on the Board of Directors of The Cancer Trust, a not-for-profit organization focused on the formation of collaborative research consortia comprised of comprehensive cancer centers, as well as on the Advisory Council of the Center for Radiological Research at Columbia University and the Corporate Advisory Board at the Cold Spring Harbor Laboratory. Mr. Jakimo holds a B.A. in Mathematics from Colgate University and an M.B.A. and J.D. from Harvard University.